PubRank

C Marcocci

Author PubWeight™ 86.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998 3.98
2 Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000 2.06
3 Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study. Surgery 1999 1.92
4 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989 1.80
5 Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab 2012 1.78
6 Minimally invasive surgery for thyroid small nodules: preliminary report. J Endocrinol Invest 1999 1.77
7 Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab 1995 1.62
8 Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency. J Endocrinol Invest 1990 1.46
9 Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983 1.40
10 Endoscopic parathyroidectomy: report of an initial experience. Surgery 1998 1.28
11 Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 1998 1.28
12 Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 1993 1.23
13 Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006 1.19
14 A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol 2002 1.14
15 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem Biophys Res Commun 1981 1.13
16 Endoscopic parathyroidectomy by a gasless approach. J Laparoendosc Adv Surg Tech A 1998 1.12
17 Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest 1997 1.11
18 A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001 1.10
19 More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 1989 1.08
20 Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells. J Biol Chem 1985 1.05
21 Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders. J Endocrinol Invest 1983 1.02
22 Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol 2008 1.01
23 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? J Clin Endocrinol Metab 1995 0.96
24 The role of PPARγ for the osteoblastic differentiation. J Endocrinol Invest 2010 0.94
25 Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease. Ann N Y Acad Sci 1986 0.93
26 Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer 2007 0.92
27 Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab 1993 0.92
28 Solubilization of human thyroid microsomal antigen. J Clin Endocrinol Metab 1979 0.92
29 Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2000 0.91
30 Spontaneous short-term remission of primary hyperparathyroidism from infarction of a parathyroid adenoma. J Endocrinol Invest 2004 0.91
31 Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract 2002 0.91
32 A questionnaire survey on the management of Graves' orbitopathy in Europe. Eur J Endocrinol 2006 0.91
33 Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol 1996 0.90
34 Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int 2003 0.89
35 Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1997 0.88
36 Studies on thyroid cell surface antigens using cultured human thyroid cells. Clin Exp Immunol 1982 0.88
37 Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res 1984 0.88
38 Orbital radiotherapy for Graves' ophthalmopathy. Thyroid 1998 0.88
39 Increased prevalence of primary hyperparathyroidism in treated breast cancer. J Endocrinol Invest 2001 0.87
40 Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects. J Endocrinol Invest 2010 0.86
41 Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells. Endocrinology 1984 0.86
42 [Guidelines for the diagnosis, prevention and treatment of osteoporosis]. Reumatismo 2010 0.85
43 Graves' disease and Turner's syndrome. J Endocrinol Invest 1981 0.85
44 L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986 0.84
45 Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990 0.84
46 Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. J Endocrinol Invest 2011 0.84
47 Comparison of radioassay and haemagglutination methods for anti-thyroid microsomal antibodies. Clin Exp Immunol 1978 0.84
48 Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 1989 0.83
49 No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999 0.83
50 Clinical approach to goitre. Baillieres Clin Endocrinol Metab 1988 0.83
51 Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 1997 0.83
52 Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J Endocrinol Invest 2007 0.82
53 Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J Endocrinol Invest 2002 0.82
54 Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique. J Neurosurg Sci 1990 0.82
55 Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves. J Endocrinol Invest 2005 0.82
56 Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas. Endocr Relat Cancer 2010 0.82
57 Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 1998 0.82
58 Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease. J Endocrinol Invest 1983 0.81
59 Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients. Mol Cell Endocrinol 2000 0.81
60 Total thyroid ablation in Graves' orbitopathy. J Endocrinol Invest 2015 0.81
61 Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids. Clin Endocrinol (Oxf) 2000 0.80
62 Lateral wall orbital decompression in Graves' orbitopathy. Int J Oral Maxillofac Surg 2009 0.80
63 Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 2004 0.80
64 An update on medical management of Graves' ophthalmopathy. J Endocrinol Invest 2005 0.80
65 Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 2011 0.80
66 Thyroid autoantigens and their relevance in the pathogenesis of thyroid autoimmunity. Biochimie 1989 0.79
67 Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease. J Endocrinol Invest 1982 0.79
68 Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. J Endocrinol Invest 2010 0.79
69 Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses. Eur Radiol 1997 0.79
70 Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment. J Endocrinol Invest 2008 0.79
71 Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy. J Clin Endocrinol Metab 1996 0.79
72 Post-menopausal osteoporosis: is it an autoimmune disease? J Endocrinol Invest 2005 0.79
73 Six novel MEN1 gene mutations in sporadic parathyroid tumors. Hum Mutat 2000 0.78
74 Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur J Endocrinol 2003 0.78
75 Thyroid autoimmunity and thyroid autonomy. Acta Med Austriaca 1990 0.78
76 GH secretion is impaired in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2002 0.78
77 Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid. J Endocrinol Invest 2010 0.78
78 The impact of thyroidectomy on parathyroid glands: a biochemical and clinical profile. J Endocrinol Invest 2007 0.78
79 Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla). Endocrinology 1982 0.78
80 Cutaneous metastasis of a radiation-associated thyroid medullary carcinoma. J Endocrinol Invest 1984 0.78
81 Measurement of thyroid cell surface antibodies by radioassay using human cultured thyroid cells. J Endocrinol Invest 1982 0.78
82 Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): evidence for a role of RAP in the Tg biosynthetic pathway. J Endocrinol Invest 2003 0.78
83 A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors. J Endocrinol Invest 2004 0.77
84 High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience. J Endocrinol Invest 2011 0.77
85 Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous? J Endocrinol Invest 2003 0.77
86 Contrast-enhanced color Doppler ultrasonography in suspected parathyroid lesions. Acta Radiol 2000 0.77
87 Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin. Endocrinology 1987 0.77
88 Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1992 0.77
89 [Video-assisted parathyroidectomy: a series of 85 cases]. Chirurgie 1999 0.76
90 Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy. Horm Res 1987 0.76
91 On the effects of radioiodine therapy on Graves' ophthalmopthy. Thyroid 1998 0.76
92 Identification and characterization of a novel de novo mutation (L346V) in the thyroid hormone receptor beta gene in a family with generalized thyroid hormone resistance. Eur J Endocrinol 1997 0.75
93 Radioiodine therapy and Graves' ophthalmopathy. Thyroid 1996 0.75
94 Recent progress in the study of thyroid autoantigens. Ann Ital Med Int 1988 0.75
95 Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer? J Endocrinol Invest 2012 0.75
96 A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1. Eur J Endocrinol 1999 0.75
97 Studies on the mechanism responsible for thyrotropin-induced expression of microsomal/peroxidase antigen in FRTL-5 cells. Endocrinology 1988 0.75
98 [CT of the orbit in Graves' ophthalmopathy]. Radiol Med 1990 0.75
99 Growth hormone secretion in primary and secondary hyperparathyroidism. J Endocrinol Invest 2005 0.75
100 [A case of hyperphosphatasemic osteoectasia in an adult]. Radiol Med 1988 0.75
101 [Preoperative imaging in the detection of parathyroid tumefaction in patients with primary hyperparathyroidism. The authors' own experience]. Radiol Med 1995 0.75
102 Selenium in endocrinology. Foreword. J Endocrinol Invest 2013 0.75
103 Orbital irradiation in the treatment of Graves' ophthalmopathy. Bull Soc Belge Ophtalmol 1988 0.75
104 A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism. J Endocrinol Invest 2014 0.75
105 Increased level of thyroglobulin mRNA in a human familial goiter. J Endocrinol Invest 1987 0.75
106 Screening for risk of delivery of a hypothyroid baby. Lancet 1986 0.75
107 MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism. J Endocrinol Invest 2002 0.75
108 [Current findings in thyroid autoimmunity]. Rev Med Liege 1988 0.75
109 Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice. J Endocrinol Invest 2008 0.75
110 Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves' ophthalmopathy. J Endocrinol Invest 2005 0.75
111 Sodium/proton exchange in FRTL-5 thyroid cells: role in the maintenance of intracellular pH and TSH-stimulated cell growth. Acta Endocrinol Suppl (Copenh) 1987 0.75
112 Role of the adenylate cyclase-cAMP system on TSH-stimulated thyroid cell growth. Acta Endocrinol Suppl (Copenh) 1987 0.75
113 Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones. J Endocrinol Invest 2002 0.75
114 Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid? J Endocrinol Invest 2008 0.75
115 Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but.... J Clin Endocrinol Metab 1995 0.75
116 [Treatment of Basedow's ophthalmopathy: a comparative evaluation of systemic or retrobulbar administration of corticosteroids associated with orbital radiotherapy]. Ann Ital Med Int 1990 0.75
117 Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB). J Endocrinol Invest 2014 0.75
118 [Orbital decompression in Grave's disease: comparison of techniques]. Acta Otorhinolaryngol Ital 1999 0.75
119 Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidism. Radiol Med 2007 0.75
120 TSH and biogenic amine signals in the regulation of thyroid function: independent regulation by protein kinase C and G proteins. Acta Endocrinol Suppl (Copenh) 1987 0.75